LXRX
Lexicon Pharmaceuticals Inc
Price:  
0.89 
USD
Volume:  
15,638,525.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LXRX Relative Valuation

-1956.6%
Upside

As of 2024-12-12, the Relative Valuation of Lexicon Pharmaceuticals Inc (LXRX) is (16.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.89 USD, the upside of Lexicon Pharmaceuticals Inc based on Relative Valuation is -1956.6%.

The range of the Relative Valuation is (16.84) - (18.71) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 28.1x - 44.9x 34.7x
Forward P/E multiples 19.8x - 31.3x 20.5x
Fair Price (16.84) - (18.71) (16.52)
Upside -1992.9% - -2202.8% -1956.6%
0.89 USD
Stock Price
(16.52) USD
Fair Price

LXRX Relative Valuation - Historical P/E Data

Date P/E
2024-12-10 -1.22
2024-12-09 -1.23
2024-12-06 -1.18
2024-12-05 -1.09
2024-12-04 -1.14
2024-12-03 -1.19
2024-12-02 -1.34
2024-11-29 -1.34
2024-11-27 -1.34
2024-11-26 -1.37
2024-11-25 -1.36
2024-11-22 -1.44
2024-11-21 -1.29
2024-11-20 -1.35
2024-11-19 -1.47
2024-11-18 -1.51
2024-11-15 -1.63
2024-11-14 -1.77
2024-11-13 -1.82
2024-11-12 -1.99
2024-11-11 -2.12
2024-11-08 -2.12
2024-11-07 -2.17
2024-11-06 -2.02
2024-11-05 -1.99
2024-11-04 -2.01
2024-11-01 -2.04
2024-10-30 -3.26
2024-10-29 -3.39
2024-10-28 -3.11
2024-10-25 -3.01
2024-10-24 -3.07
2024-10-23 -3.11
2024-10-22 -3.24
2024-10-21 -3.26
2024-10-18 -3.47
2024-10-17 -3.36
2024-10-16 -3.19
2024-10-15 -2.99
2024-10-14 -2.99
2024-10-11 -2.91
2024-10-10 -2.82
2024-10-09 -2.72
2024-10-08 -2.81
2024-10-07 -2.81
2024-10-04 -2.82
2024-10-03 -2.69
2024-10-02 -2.69
2024-10-01 -2.64
2024-09-30 -2.62